All lobbying filings

E3 STRATEGIC CONSULTING GROUP

Lobbying for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Association

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $50,000.00 income · posted Jan 16, 2026

Official filing document

Bills named in this filing 5

S 1040
Drug Competition Enhancement Act
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
HR 4317
PBM Reform Act of 2025
HR 5256
340B ACCESS Act
S 3345
PBM Price Transparency and Accountability Act

Lobbying activity 1

Pharmacy

Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, trade, and employment issues, 340B program, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 4317, PBM Reform Act of 2025; H.R. 5256, 340B ACCESS Act;" S. 3345 - "PBM Price Transparency and Accountability Act."

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.